| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 312.232 | 313.185 | 310.523 | 270.165 | 208.484 | 213.763 | 195.635 | 201.271 | 241.907 | 289.797 |
| Total Income - EUR | 313.516 | 313.362 | 310.703 | 270.166 | 209.560 | 228.277 | 195.636 | 206.384 | 241.908 | 290.327 |
| Total Expenses - EUR | 290.956 | 299.307 | 289.118 | 263.049 | 202.921 | 208.626 | 184.117 | 213.436 | 222.127 | 275.695 |
| Gross Profit/Loss - EUR | 22.561 | 14.055 | 21.584 | 7.117 | 6.638 | 19.651 | 11.519 | -7.053 | 19.781 | 14.631 |
| Net Profit/Loss - EUR | 18.487 | 11.288 | 17.381 | 4.397 | 4.500 | 17.642 | 9.849 | -8.866 | 17.327 | 11.844 |
| Employees | 7 | 7 | 8 | 9 | 7 | 7 | 7 | 7 | 7 | 7 |
Check the financial reports for the company - Kemapharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.094 | 6.859 | 5.524 | 21.638 | 16.110 | 30.423 | 23.718 | 2.751 | 1.960 | 1.386 |
| Current Assets | 158.421 | 100.436 | 111.772 | 78.879 | 78.781 | 91.968 | 81.912 | 86.003 | 122.321 | 144.128 |
| Inventories | 45.540 | 45.844 | 41.325 | 32.179 | 42.129 | 54.058 | 43.534 | 44.886 | 73.768 | 81.921 |
| Receivables | 90.532 | 27.751 | 69.676 | 45.464 | 36.170 | 37.788 | 38.233 | 40.513 | 40.239 | 44.338 |
| Cash | 22.350 | 26.842 | 771 | 1.236 | 481 | 122 | 145 | 604 | 8.315 | 17.869 |
| Shareholders Funds | 67.450 | 15.701 | 19.681 | 10.823 | 15.113 | 32.469 | 41.597 | 32.860 | 35.936 | 47.580 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 99.065 | 91.595 | 97.615 | 89.694 | 79.778 | 89.922 | 64.033 | 55.895 | 88.346 | 98.672 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Kemapharm S.r.l.